Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03534258 · ClinicalTrials.gov registry record
Does Use of Rapid Response EEG Impact Clinical Decision Making
A clinical trial, sponsored by Ceribell.
- Completed
- Registry status
- 164
- Enrollment target
NCT03534258 is a clinical trial that has completed, run by Ceribell. The registered enrollment target is 164 participants.
The verdict
NCT03534258 has completed, sponsored by Ceribell.
- COMPLETED
- Registry status
- 164 participants
- Enrollment target
Study Summary
This study is designed as a prospective, non-randomized, observational, multicenter clinical trial. The primary aim of this study is to observe if the use of the rapid responds electroencephalography (EEG) system impacts physician decision making. Secondary aims include exploring the safety and performance information of the Ceribell EEG system compared to conventional EEG system. The study will recruit physicians (Faculty physicians and Trainees) at up to five institutions and examine the impact of rapid response EEG when providing care to patients in whom EEG recording has been ordered for clinical reasons.
Interventions
- DEVICE Ceribell Rapid Response EEG, Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2018-04-30 |
| Est. Completion | 2019-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03534258
The ClinicalTrials.gov registry entry for NCT03534258 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ceribell, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ceribell Rapid Response EEG, Survey is the first listed.
NCT03534258 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03534258 about?
NCT03534258 is a clinical study titled "Does Use of Rapid Response EEG Impact Clinical Decision Making". This study is designed as a prospective, non-randomized, observational, multicenter clinical trial. The primary aim of this study is to observe if the use of the rapid responds electroencephalography (EEG) system impacts physician decision making. Secondary aims include exploring the safety and perf...
What is the current status of trial NCT03534258?
This trial is currently completed. The enrollment target is 164 participants. The study started on 2018-04-30. Estimated completion is 2019-07-31.
What interventions are being tested in trial NCT03534258?
The interventions under investigation include: Ceribell Rapid Response EEG, Survey (DEVICE).
Who is sponsoring clinical trial NCT03534258?
This trial is sponsored by Ceribell, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.